Log-in / Create Account  
Session Information
2007 BIO International Convention
Click here to go to the previous page
Multimodal and Combination Drugs: Strategies for Cardiometabolic Diseases
Track : Drug Discovery and Development
Program Code: DDD040
Date: Wednesday, May 9, 2007
Time: 9:15 AM to 10:45 AM  
Location: 259 AB
CHAIR :
Bart Staels, Professor and Vice President, Science, University Lille 2/ GENFIT
SPEAKER (S):
Ulrich Kintscher, Professor and Vice President, Science, Center for Cardiovascular Research, Institute of Pharmacology
Ron Law, PhD, JD, Senior Director of Medical & Scientific Product Evaluation, Takeda Pharmaceuticals North
James Stolzenbach, Divisional Vice President, Heart Failure and Dyslipidemia, Abbott
Description
This session will allow us to understand the arguments for the application of multimodal and fixed-dose combination therapy to successfully treat multi-risk-factor cardiometabolic disorders.



Objectives:
  • Increase awareness of cardiometabolic disease and related risk factors, the biggest health problem facing the world today.

  • Offer better understanding of the rationale behind fixed-dose combination and multimodal therapy in both oncology and cardiometabolic disease areas.

  • Outline innovative therapy strategy for better and safer treatments.

    • Streaming Audio with
    PowerPoint Slides
    (Code: DDD040)
      
    This session is a part of:
    Drug Discovery and Development 2-DAY TRACK
    Complete Set of BIO Online / CD-ROM - All 23 Tracks.